Urinary glycosidases as markers of renal dysfunction in patients with cirrhosis.

被引：0
|
作者：
Johnston, DE [1 ]
Choi, HJJ [1 ]
Arora, S [1 ]
Fry, D [1 ]
Glew, RH [1 ]
机构：
[1] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1685
引用
收藏
页码：582A / 582A
页数：1
相关论文
共 50 条
  • [21] Cirrhosis and Renal Dysfunction
    Ayar, Yavuz
    Ersoy, Alparslan
    Soyak, Halime
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2016, 25 : 53 - 59
  • [22] Renal dysfunction in cirrhosis
    Urrunaga, Nathalie H.
    Mindikoglu, Ayse L.
    Rockey, Don C.
    CURRENT OPINION IN GASTROENTEROLOGY, 2015, 31 (03) : 215 - 223
  • [23] Renal dysfunction and cirrhosis
    Durand, Francois
    Olson, Jody C.
    Nadim, Mitra K.
    CURRENT OPINION IN CRITICAL CARE, 2017, 23 (06) : 457 - 462
  • [24] ACUTE KIDNEY INJURY IS ASSOCIATED WITH REVERSIBLE PLATELET DYSFUNCTION IN HOSPITALIZED PATIENTS WITH DECOMPENSATED CIRRHOSIS.
    Zanetto, Alberto
    Rinder, Henry
    Deng, Yanhong
    Ciarleglio, Maria
    Wilson, Francis P.
    Bulato, Cristiana
    Simioni, Paolo
    Garcia-Tsao, Guadalupe
    GASTROENTEROLOGY, 2020, 158 (06) : S1301 - S1301
  • [25] Increased intestinal permeability in patients with cirrhosis.
    Piquet, MA
    Laurent, D
    Manceau, S
    Even, C
    Collet, T
    Arsene, D
    Jauzac, P
    Verwaerde, JC
    Dao, T
    GASTROENTEROLOGY, 1997, 112 (04) : A1360 - A1360
  • [26] Aquaretic effects of niravoline in patients with cirrhosis.
    Gadano, A
    Moreau, R
    Trombino, C
    Giuily, N
    Valla, D
    Augustin, M
    Sinnassamy, P
    Lebrec, D
    HEPATOLOGY, 1996, 24 (04) : 1285 - 1285
  • [27] Propranolol ameliorates hypersplenism in patients with cirrhosis.
    Sakai, K
    Iwao, T
    Oho, K
    Nakano, R
    Sato, M
    Miyamoto, Y
    Kumamoto, M
    Sata, M
    Toyonaga, A
    GASTROENTEROLOGY, 2000, 118 (04) : A1484 - A1484
  • [28] Prevalence of bone disease in patients with cirrhosis.
    Rudow, DL
    Shane, E
    Dodd, VA
    Russo, MW
    Emond, JC
    Brown, RS
    HEPATOLOGY, 2000, 32 (04) : 239A - 239A
  • [29] Pharmacokinetics of esomeprazole in patients with liver cirrhosis.
    Sjovall, H
    Hagman, I
    Holmberg, J
    Rohss, K
    Hassan-Alin, M
    GASTROENTEROLOGY, 2000, 118 (04) : A21 - A21
  • [30] Cryptococcal infection in patients with liver cirrhosis.
    Kim, JG
    Oh, MD
    Choe, KW
    Lee, HS
    Kim, CY
    GASTROENTEROLOGY, 1997, 112 (04) : A1301 - A1301
12345